Product Details for NDA 020738
TEVETEN (EPROSARTAN MESYLATE)
EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: EPROSARTAN MESYLATE
Proprietary Name: TEVETEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020738
Product Number: 004
Approval Date: Dec 22, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
TEVETEN (EPROSARTAN MESYLATE)
Proprietary Name: TEVETEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020738
Product Number: 004
Approval Date: Dec 22, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: EPROSARTAN MESYLATE
Proprietary Name: TEVETEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020738
Product Number: 005
Approval Date: Dec 22, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
TEVETEN (EPROSARTAN MESYLATE)
Proprietary Name: TEVETEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020738
Product Number: 005
Approval Date: Dec 22, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: EPROSARTAN MESYLATE
Proprietary Name: TEVETEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020738
Product Number: 006
Approval Date: May 27, 1999
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: TEVETEN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020738
Product Number: 006
Approval Date: May 27, 1999
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information